Public Company News

Webull Reduces Minimum ASX Trading Fee To $1

* Webull Australia now offers the lowest-cost CHESS-sponsored brokerage fee minimums for trading ASX shares * The new pricing structure is paired with Webull's industry-leading technology and free live pricing data * $1.00 minimum fees will be made available to Australian clients from 20 Oc...

2025-10-20 06:00 2016

Significant OS Benefit with Cadonilimab in First-Line Advanced Gastric Cancer: Final Analysis of COMPASSION-15 Presented at ESMO 2025

HONG KONG, Oct. 19, 2025 /PRNewswire/ -- On October 19, 2025, Akeso (9926.HK) announced the final analysis results from the COMPASSION-15/AK104-302 study at the 2025 European Society of Medical Oncology Congress (ESMO 2025) .  COMPASSION-15 is a Phase III clinical trial evaluating cadonilimab, Ak...

2025-10-19 23:42 1510

HARMONi-6 Data: mPFS 11.14 Months (HR=0.6, P<0.0001) Simultaneously Released at ESMO and in The Lancet

* Ivonescimab plus chemotherapy demonstrated a median PFS of 11.14 months, PFS HR=0.60, P < 0.0001. * The absolute difference in median PFS between the two groups was 4.24 months (ΔPFS = 4.24 months), indicating significantly prolonged progression-free survival with ivonescimab combination th...

2025-10-19 23:37 1372

Case Report | Preliminary Clinical Data of CARsgen's Allogeneic BCMA CAR-T Product CT0596 for the Treatment of Primary Plasma Cell Leukemia

SHANGHAI, Oct. 19, 2025 /PRNewswire/ -- Primary plasma cell leukemia (pPCL) is a rare and highly aggressive plasma cell malignancy, often associated with complex genetic abnormalities. There is currently no standard treatment regimens, and conventional therapies for multiple myeloma are typically...

2025-10-19 14:00 1603

Kelun-Biotech Presents Positive Results of Phase 3 Clinical Study OptiTROP-Breast02 for Sacituzumab Tirumotecan in Advanced HR+/HER2- Breast Cancer at 2025 ESMO

CHENGDU, China, Oct. 18, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held inBerlin, Germany, results from a Phase 3 OptiTROP-Breast02 study of the Company's trophoblast cel...

2025-10-18 22:46 2122

Manulife Hong Kong and JUST FEEL Promote Emotional Well-Being with City's First "My Flag Day"

500 family volunteers distribute over 10,000 free flags to encourage the public to share their feelings HONG KONG, Oct. 18, 2025 /PRNewswire/ -- Manulife Hong Kong and JUST FEEL, a Hong Kong-based NGO dedicated to emotional education, successfully held the city's first-ever "My Flag Day" today. ...

2025-10-18 16:23 3147

Research Updates on a Phase III Clinical Trial of Anbenitamab (KN026) Presented at ESMO Congress 2025 LBA Oral Presentation Session

SUZHOU, China, Oct. 18, 2025 /PRNewswire/ -- Alphamab Oncology (Stock Code: 9966.HK) announced that the first interim analysis results of a phase III clinical trial of anbenitamab injection (KN026), independently developed by the Company and co-developed with JMT-Bio Technology Co., Ltd., a wholl...

2025-10-18 14:59 2124

Yunji Technology Debuts on HKEX, Partners with Luxshare Precision to Accelerate Global Expansion

HONG KONG, Oct. 18, 2025 /PRNewswire/ -- Beijing Yunji Technology Co., Ltd. (the "Company"; Stock code: 2670) today announced that shares of the Company have started to be traded on the Main Board of The Stock Exchange of Hong Kong Limited under the stock code "2670".

2025-10-18 10:12 3623

Agoda Joins as Main Sponsor of Singapore's Iconic #HuntTheMouse Cash Hunt

SINGAPORE, Oct. 18, 2025 /PRNewswire/ -- Digital travel platform Agoda has signed up as a main sponsor for the much-anticipated #HuntTheMouse cash hunt in Singapore. Running from 16 October to 14 December 2025, the event is organized by Singaporean company Sqkii and offers participants a chance to...

2025-10-18 09:19 1870

PINTEC's Subsidiary ZIITECH Makes Its Debut at Tech Week Singapore 2025

BEIJING, Oct. 17, 2025 /PRNewswire/ -- Pintec Technology Holdings Limited (Nasdaq: PT) ("PINTEC" or the "Company"), a leading technology platform committed to enabling innovative financial and digital solutions for businesses worldwide, today announced that its subsidiary ZIITECH PTY LTD ("ZIITEC...

2025-10-18 04:05 3269

CLPS Incorporation Reports Financial Results for the Second Half and Full Year of Fiscal 2025

HONG KONG, Oct. 17, 2025 /PRNewswire/ -- CLPS Incorporation (the "Company" or "CLPS") (Nasdaq: CLPS), today announced its financial results for the six months and full year of fiscal 2025 ended June 30, 2025. During this fiscal year, we faced a significant challenge when our long-standing and hi...

2025-10-17 21:23 3419

NYSE Content Advisory: Pre-Market Update + Automakers await 5-year tariff relief extension

NEW YORK, Oct. 17, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.    NYSE Content Advisory: Pre-Market Update + Automakers await 5-ye...

2025-10-17 20:55 2238

SparkRWA Expands AI Applications to Empower the Global Green Economy and Drive Sustainable Innovation

HONG KONG, Oct. 17, 2025 /PRNewswire/ -- GIBO Holdings Ltd. (NASDAQ: GIBO), Asia's leading innovation-driven creative ecosystem, today announced an extended application of its proprietary AI technologies under theSparkRWA Green Creator Framework, marking a major step toward integrating artificial...

2025-10-17 20:43 1862

Re-imagining Neo-Pragmatic Lifestyle: EPWK Launches Strategic Upgrade with "EPWK Curated Goods"

XIAMEN, China, Oct. 17, 2025 /PRNewswire/ -- "We grew weary of life's monotony, so we embarked on a journey to find 'EPWK Curated Goods.' Each selected item must pass our stringent 'Three Goods' standard: Good-looking, Good-to-use, and Good-surprise. We believe that truly excellent products can i...

2025-10-17 20:36 1446

Kelun-Biotech's Core product Trastuzumab Botidotin Approved for Marketing by NMPA for HER2-positive BC

CHENGDU, China, Oct. 17, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company's human epidermal growth factor receptor 2 (HER2)-directed antibody-drug conjugate (ADC) trastuzumab botidotin (also known as A166)  was approved for marketi...

2025-10-17 20:22 1877

Autoliv: Financial Report July - September 2025

STOCKHOLM, Oct. 17, 2025 /PRNewswire/ --  Q3 2025: Record 3rd quarter sales, operating income and EPS Financial highlights Q3 2025 $2,706 million net sales 5.9% net sales increase 3.9% organic sales growth* 9.9% operating margin 10.0% adjusted operating margin* $2.28 diluted EPS, 31% increase $2....

2025-10-17 20:10 1726

Minesto part of Swedish high-level delegation to South Korea

GOTHENBURG, Sweden, Oct. 17, 2025 /PRNewswire/ -- This week, leading ocean energy technology developer Minesto was part of a high-level Swedish delegation toSouth Korea aiming to explore new partnerships and strengthen bilateral collaboration in the green transition. The delegation, led by HRH Cr...

2025-10-17 20:05 1298

Erayak Power Solution Group Inc. Establishes U.S. Subsidiary to Advance Global Expansion and Reinforce Long-Term Growth Strategy

WENZHOU, China, Oct. 17, 2025 /PRNewswire/ -- Erayak Power Solution Group Inc. ("Erayak" or the "Company") (Nasdaq: RAYA), a leading manufacturer and exporter of advanced power solution products, today announced the establishment of its U.S. subsidiary, Nexora Group Inc., marking a strategic mile...

2025-10-17 18:16 2130

KFin Technologies acquires 51% controlling stake in Ascent Fund Services for USD 35 million, expanding into the global fund administration industry

MUMBAI, India, Oct. 17, 2025 /PRNewswire/ -- KFin Technologies Limited  ("KFintech") (BSE: 543720) (NSE: KFINTECH), a leading provider of investor and issuer solutions, has completed the acquisition of a 51% controlling stake in Ascent Fund Services (Singapore) Pte. Lt...

2025-10-17 17:39 2377

SEMIFIVE Submits Securities Registration for KOSDAQ Listing

* Secures Only 'One-Stop AI ASIC Solution' in Korea and Big-Die Design Capability * 2025 Q3 Cumulative Revenue Expected to Surpass KRW 90 Billion; Large AI Chip Mass Production Begins, Growth to Accelerate from Q4 * Wins Successive AI Chip Design Projects for Global Customers, Expanding int...

2025-10-17 17:25 1447
1 ... 60616263646566 ... 1667

Week's Top Stories